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Abstract
Hepatitis Delta Virus (HDV) infects only patients that are already infected by hepatitis B virus (HBV) because this is
sub satellite virus which depends on and propagate only in the presence of HBV. HDV causes co-infection or super
infection with sever complication as compared to only HBV infection. No study on molecular level on HDV is
available from this region; therefore, the aim of this study was to found out the molecular epidemiology of HDV
(as a co-infection with HBV) in different geographical regions of Pakistan.
Total 228 HBsAg positive samples were received for the study from different geographical regions of the country.
Only HBV DNA PCR positive samples were further utilized for the presence of HDV RNA. For this purpose, HDV RNA
and HBV DNA was extracted and amplified using reverse transcriptase polymerase chain reaction (RT-PCR), nested
PCR and real-time PCR.
Out of the total 228 HBsAg positive samples, HBV DNA was detected in total 190 (83.3%) samples belonged to
different patients. Of these 190 patients, HDV RNA was observed in 53 (28%) patients. Of the 53 HDV positive cases,
37 (69.8%) were males and 16 (30.2%) were female patients. The percentage of dual infection was found higher
significantly (p < 0.05) in male patients as compared to female patients. Total 41 (26.8%) patients were below 40
years and 13 (31.7%) were above 40 years of age. No significant difference was seen in patients with ages above or
below 40 years. In the provinces of Sindh, Khyber Pakhtoonkhaw and Punjab the observed prevalence of HDV was
67%, 6% and 4% respectively.
In conclusion, the HDV infection is not uncommon in Pakistan and its prevalence is higher significantly in the
Province of Sindh (p < 0.01) and male six (p < 0.05).
Introduction
Hepatitis Delta virus (HDV) infection is present globally
and infects human being already infected by Hepatitis B
virus (HBV). Hepatitis Delta is mostly present in Africa;
South America, Romania, Russia and the Mediterranean
region included Southern Italy [1]. HDV was first dis-
covered by Rizzetto in the patients that were already
infected by HBV in year 1980 [2]. HDV is a sub-satellite
virus associated with HBV to cause severe acute and
chronic forms of liver infection [3]. Tthe particle size of
HDV is about 36-nm that require hepatitis B surface
antigen (HBsAg) for their enveloped and transmission
[4]. The HDV genome is a circular, negative sense,
single-strand RNA, which is approximately 1700 nucleo-
tides in length [5]. These nucleotides is assemble with
two viral proteins HD Ag-S and HDAg-L to form a
ribonucleoprotein [6]. These Two Hepatitis D Ag pro-
teins are translated from viral mRNA and this process is
called RNA editing [7]. The dual infection of HBV and
HDV occurs in the form of co-infection or as a super-
infection. The Super infection of HDV with HBV caused
a progressive chronic liver disease up to (80%), which
further enhances liver cirrhosis and hepatocellular carci-
noma (HCC). Co-infection by both HBV and HDV
viruses causes more severe acute liver disease and is a
higher risk for the development of fulminate hepatitis
compared to only HBV infected patients [8].
It has been estimated that approximately 5% of HBV
carriers are co-infected with HDV, leading to an esti-
mated 15 million persons infected with HDV worldwide
[9]. HDV infection has a worldwide distribution, but its
* Correspondence: idreeskhan96@yahoo.com
† Contributed equally
4Division of Molecular Virology, CEMB, University of the Punjab Lahore-
53700, Pakistan
Full list of author information is available at the end of the article
Khan et al. Virology Journal 2011, 8:420
http://www.virologyj.com/content/8/1/420
© 2011 Khan et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
frequency varies greatly throughout different geographic
regions. It is highly endemic in the Middle East, in the
Mediterranean area, in the Amazonian region, and in
several African countries [10].
Several studies propose that most people acquired
HDV infections through parenteral and sexual routes
[11-13]. Furthermore the reported seroprevalence of
HDV infection among HBV carriers is significantly
higher in intravenous drug users (IDU) compared to the
non-IDU population [14].
In Pakistan, the prevalence of chronic HBV infection
is estimated to be 16-57% in general population predo-
minantly in younger males living in rural areas [15,16].
However, in these studies enzyme linked immunosor-
bant assay (ELISA) based assays were utilized for the
estimation of this prevalence rate. For the true preva-
lence of HDV-HBV co-infection, we used molecular
based methods such as PCR and real-time PCR for the
detection of HBV DNA and HDV RNA in HBsAg posi-
tive samples from patients’ different geographical
regions of Pakistan.
Methods
Source of Clinical Samples
A total of 228 HBsAg positive serum samples by enzyme
linked immunosorbant assay (ELISA) were received at
Genome Centre for Molecular Based Diagnostics &
Research (GCMBDR) Lahore, Pakistan from different
geographical regions of the country for HBV DNA and/
or HDV RNA detection from January 2011 to March
2011. GCMBDR is a state of the art molecular based
diagnostic facility that provides general public sensitive,
specific and more reliable diagnostic tests on cost-to-
cost basis utilizing PCR and real-time PCR methods. All
sera were stored in aliquots at -70°C till was used for
nucleic acid (DNA/RNA) isolation. Demographic char-
acteristics, serological and biochemical data was avail-
able for 190 patients (male 121; female 69, mean age 42
years [range, 6-82 ± SD] years)) with chronic HBV
infection and were thus included in the data analysis.
These samples belonged to different provinces/geogra-
phical regions of Pakistan. Seventy were from Sindh, 66
belonged to Khyber Pakhtoonkhaw (KPK) and 54 were
from Punjab. There was no need for separate written
informed consent from subjects for this study, since this
analysis was a part of the original protocol in a routine
workup of Molecular Diagnostics.
HBV DNA extraction and real-time PCR amplification
Qualitative and quantitative detection of serum HBV
DNA in all patients were performed by SmartCycler II
real-time PCR (Cepheid, USA) with an internal RNA
standard derived from the 5’ UTR. The utilized kits for
HBV DNA extraction and real-time PCR were done
according to the procedures given in the kit protocols
(Sacace Biotechnologies Italy). Sensitivity of the assay is
20 IU per ml blood sample. Specificity of the assay is
about 99%.
Extraction of HDV RNA and complementary DNA (cDNA)
synthesis
HDV RNA was extracted from 100 μL serum sample
using Gentra RNA isolation kit (Life Technologies,
USA). About 50 ng of the extracted RNA was reverse
transcribed into cDNA with Molony-murin leukemia
virus reverse transcriptase enzyme (Gibco BRL, Life
Technologies USA). The thermal cycling was carried out
in thermal cycler for 50 minutes at 37°C. The reaction
mixture for the preparation of cDNA, for a single reac-
tion contained 8 50 mM Tris-HCl (pH 8.3), 7.5 mM
KCl, 3 mM MgCl2, 0.1 M DTT, 10 mM dNTPs and 200
U of MMLV reverse transcriptase enzyme. At the end of
reaction, MMLV was heat inactivated at 95°C for 5
minutes.
Qualitative detection
The detection of the HDV cDNA was carried using
nested PCR. The Qualitative detection of hepatitis
Delta virus was done in two rounds. First round PCR
was carried out in a PCR reaction tube that contained
8 μL of mix I which having 2.5 mM MgCl2, 100 μM
concentration of each of the four deoxynucleotides, 10
pM of each outer sense nucleotides 695-718 {5 ’-
CATGGTCCCAGCCTCCTCGCTGGC-3’} and outer
anti-sense primers; nucleotides 873-896 {5 ’-
CCGCGAGGAGGTGGAGATGCCATG-3’} [17], and 1
U of Taq DNA polymerase Enzyme. In the thermal
cycler, firstly the samples were incubated on 95°C for
2 min then it was followed by 35 cycles consisting of
95°C for 1 min, 64°C for 1 min and 72°C for 1 min.
The second round (nested PCR) PCR was also carried
out in a reaction tube that contained 8 μL of mix II
which had 2.5 mM MgCl2, a 100 μM concentration of
each of the four deoxynucleotides, 10 pM of each
inner sense nucleotides 729-748 (5’-CAACATTCC-
GAGGGGA CCGT-3’) and inner anti-sense primers
nucleotides 846-865 (5’-GAAGGAAGGCCCTCGA-
GAACAAGA-3’) [17]. For standard PCR to seen con-
tamination we used the negative and reagent controls
along with samples in each run. Finally the PCR pro-
ducts were electrophoresis on a 2% agarose gel pre-
pared in 1× Tris-borate-EDTA (TBE) buffer, stained
with ethidium bromide, and evaluated under UV tran-
silluminator. The sizes of PCR products were estimated
according to the migration pattern of a 50-bp DNA
ladder (Fermentas Life Sciences). The sensitivity limit
of this qualitative detection method was 10 copies per
ml blood sample.
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Statistical Analysis
All the data was analyzed and the summary statistic was
carried out by SPSS version 10.0 (a statistical package).
Variables are given in the form of rates (%). Chi Square
test was used for categorical variables that measured
association among categorical variables. Values of less
than 0.05 were considered significant
Results
The study enrolments and patients’ disposition are
shown in Figure 1. One hundred and ninety patients
with chronic HBV who fulfilled the study criteria were
enrolled for this study out of total 288 consecutive
HBsAg positive patients. Total 98 patients samples were
excluded from the study either the volume of sera were
not sufficient for testing (n = 19) or failed to meet inclu-
sion criteria of the study (n = 79) as they were HBV
DNA negative by real-time PCR. Out of 190 enrolled
patients, 63.7% (n = 121) were males and 36.3% (n = 69)
were females. The mean age was 38 ± 11 years. The
sensitivity of the assay was excellent that is 20 IU per
ml blood sample.
Of the total 190 tested HBV positive cases, HDV RNA
was detected in 58 (28%) patients. Out the HDV positive
patients, 37 were males and 16 were females. The rates
of HDV positivity in both sexes are shown in table 1.
The HDV RNA data was also analysed Province wise
(Table 2). In the provinces of Sindh, Khyber Pakhtoon-
khaw (KPK) and Punjab the observed prevalence of
HDV was 67%, 6% and 4% respectively. The co-infection
of HDV with HBV was higher significantly in the Pro-
vince of Sindh as compared to Provinces of KPK and
Punjab. No significant difference was seen in the rates
of HBV+HDV co-infection in patients below or above
40 years of ages (Table 3).
Discussion
HDV can be caused either as a co-infection (concomi-
tant) in persons infected with HBV or as a super-infec-
tion (subsequent) in chronic HBV carriers. As it is now
an established fact that HDV is a defective virus, con-
taining particles of RNA nucleoprotein in virion-like
form, present in patients with acute hepatitis B and
chronic hepatitis that requires the presence of a hepad-
navirus (HBV) for full replication. That is why for its
penetration into the hepatocytes and assembly of virion,
it needs the help of HBV that provides the viral coat
surface antigen and can survive only in the presence of
HBV (co-infection or/and super-infection). Here we
report on the HDV-HBV co-infection or molecular epi-
demiology of HBV+HDV co-infection. Our study is the
first one to describe the molecular epidemiology of
HDV and its co-infection with HBV in different geogra-
phical regions of Pakistan. This is very important study
as it describes the dual HBV-HDV infection using mole-
cular methods. It has already been reported that in con-
trast to HBV mono-infection, HBV+HDV co-infection
leads to exacerbation and rapid progression of chronic
liver disease, hepatic failure, and deaths in patients
[18,19].
Figure 1 Study disposition and enrolments. Total 288 consecutive
HBsAg positive patient’s samples were received at Genome Centre
for Molecular based Diagnostics & Research. Of these total 98
patients samples were excluded from the study either the volume
of sera were not sufficient for testing (n = 19) or failed to meet
inclusion criteria of the study (n = 79) as they were HBV DNA
negative by real-time PCR. Total 190 patients with chronic HBV who
fulfilled the study criteria were enrolled for this study Out of 190
enrolled patients, 63.7% (n = 121) were males and 36.3% (n = 69)
were females. Total 58(28%) samples were found positive with
double infection of HBV &HDV. In the provinces of Sindh, Khyber
Pakhtoonkhaw (KPK) and Punjab the observed prevalence of HDV
was 67%, 6% and 4% respectively.
Table 1 Rate of HBV + HDV co-infection in male and
female patients





1 Male 121 37 31%
2 Female 69 16 23%
Total 190 53 28%
Table 2 Rate of HBV + HDV co-infection in different
provinces of Pakistan











3 PUNJAB 54 2 4%
Total 190 53 28%
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Several important findings emerged from the results of
this study. The first finding of the current study showed
that more than 83% of the HBsAg positive patients by
ELISA were also positive by HBV DNA PCR. HBV
+HDV co-infection was observed in 28% HBV DNA
positive patients that is very alarming. This is the true
prevalence of active HDV infection in HBV DNA posi-
tive cases. The previously conducted studies on the ser-
oprevalence of HDV infection in Pakistan have reported
the prevalence of antibodies against HDV (HDV-Ab) of
16% and 57%, respectively [15,16]. However these stu-
dies were based on ELISA methods that might give both
false positive and false negative results. In spite of this
high prevalence, no data on molecular epidemiology of
HDV in Pakistan are available. The prevalence of HDV
positive cases obtained in this study is extremely high.
More recently a high endemicity of HDV in Cameroo-
nian populations was reported by Foupouapouognigni
and colleagues [20].
Next important finding of the study is the observa-
tion that HDV rate is significantly high (p < 0.001) in
male (69.81%) as compared to female (30.18%)
patients. However the chances of this co-infection is
same in all age groups as no significant difference was
seen for the rates of co-infection in patients with ages
below or above 40 years. This finding of the current
study is contrary to the finding of another study from
Pakistan where HDV was predominant in young popu-
lation [15].
Another important finding of the present study is the
observation that rates of HDV is significantly high (P <
0.001) in ethnic group Sindhi as compared to Punjabi
and Pashtoon races. Is Sindhi racing an independent
risk factor for acquiring HDV, is question marked? To
correctly answer this question, we recommend further
conformation of this observation by other studies with
large number of patients. In our study in all three
groups the baseline characteristics of patients were simi-
lar however we were unable to establish the exact mode
of contamination that may play a major role in this high
rate of HDV in Sindh. No study on correlation of HDV-
HBV co-infection with ethnic group is available from
this region.
Also so far no epidemiological survey at molecular
level has been documented in Pakistan to investigate the
prevalence of double HBV plus HDV hepatitis infection
hence this study provides new insights and dimensions
for the molecular virologists to carry out investigations
on patients having this double hepatitis related liver dis-
orders. Further we believe that the results of the current
study enrich the limited information on co-infection and
molecular epidemiology of HDV in the region.
Conclusion
Our study showed a higher prevalence of HDV in HBV
DNA positive patients that highlights the importance of
screening for HDV infection in HBV carriers. Its preva-
lence is higher significantly in the Province of Sindh and
male six. Clinicians particularly gastroenterologist, hepa-
tologists and other medical and practitioners should be
made aware of the danger of twin infection with HDV
and HBV. Further studies, with full genome characteri-
zation of different HDV strains are required.
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